![Stephen Goodall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Stephen Goodall is the founder of Firebrick Pharma Ltd., which is founded in 2012, where he holds the title of Chief Operating Officer & Director.
He was also a Director-Pharmaceutical Development at Vapotronics, Inc. from 1999 to 2001 and the Chief Operating Officer at Viralytics Pty Ltd.
from 2008 to 2011.
Postes actifs de Stephen Goodall
Sociétés | Poste | Début |
---|---|---|
FIREBRICK PHARMA LIMITED | Fondateur | 12/04/2012 |
Anciens postes connus de Stephen Goodall
Sociétés | Poste | Fin |
---|---|---|
VIRALYTICS LTD. | Directeur des opérations | 31/08/2011 |
Vapotronics, Inc.
![]() Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Corporate Officer/Principal | 01/06/2001 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
FIREBRICK PHARMA LIMITED | Health Technology |
Entreprise privées | 2 |
---|---|
Viralytics Pty Ltd.
![]() Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Vapotronics, Inc.
![]() Vapotronics, Inc. Medical SpecialtiesHealth Technology Vapotronics, Inc. develops inhalation drug products. The company is headquartered in South Brisbane, Australia. | Health Technology |